StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

3-(10,11-Dihydro-5H-dibenzo(a,d)-cyclohepten-5-yliden)-N,N-dime-thyl-1-propanamin-hydrochlorid

Amitriptyline Hydrochloride

HCID 11065
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
549-18-8
Standard-SMILES
CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl
InChIKey
KFYRPLNVJVHZGT-UHFFFAOYSA-N
Summenformel
C20H24ClN
Durchschnittliche Molmasse
313,9 g/mol
Monoisotopische Masse
313,1597275

Überblick

Amitriptyline hydrochloride is an organic tricyclic compound.

Namen und Bezeichner

Bevorzugter Name
Amitriptyline Hydrochloride
IUPAC
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine;hydrochloride
Lokaler Name
3-(10,11-Dihydro-5H-dibenzo(a,d)-cyclohepten-5-yliden)-N,N-dime-thyl-1-propanamin-hydrochlorid
Englischer Name
Amitriptyline hydrochloride
Summenformel
C20H24ClN
Molmasse
313.86

Namen und Synonyme

Amitriptyline hydrochloride549-18-8Amitriptyline HClEtravilSyneudonNovoprotectAmitidAmitrilSaroten RetardNIH 10794CytriptylineDTXSID9033187
Weitere Namen anzeigen
endepAmitriptyline Hydrochloride (200 mg)deprexNormalnAmiplindomicaletrafonsaroten
Amitriptylini hydrochloridum26LUD4JO9KNSC-1042101-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochlorideDTXCID7013187NSC104210NSC1699101-propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride

Datenbank-Bezeichner

CAS
549-18-8
PubChem CID
11065
DTXSID
DTXSID9033187
ChEMBL
CHEMBL1200964
ChEBI
CHEBI:2667

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
3,2 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
1
Frei drehbare Bindungen
3
Schwere Atome
22
Formalladung
0
Komplexität
331

Experimentelle und physikochemische Eigenschaften

Solubility>47.1 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section166.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
196 · 196-197°C
Flammpunkt
11 °C · 11 °C
storage temp.
2 · 2-8°C
Löslichkeit
2 O: · H2O: soluble
Aggregatzustand
powder
pka
9.4 · 9.4(at 25℃)
Farbe
white to off-white
PH
4.5 · 4.5~6.0 (10g/l, 25℃)
Wasserlöslichkeit
almost transparency
Merck

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 0.7% (1 of 136) of reports.

Danger

H301 (71.3%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P260, P263, P264, P264+P265, P270, P273, P280, P301+P316, P301+P317, P305+P351+P338, P305+P354+P338, P308+P316, P317, P318, P321, P330, P337+P317, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 136 reports by companies from 21 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 2 Einträge

REACH registered substance: Amitriptyline hydrochloride (EC: 208-964-6)

Amitriptyline hydrochloride: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride: Human health tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (71.3%)

Toxikologische Informationen

Treatment · 1 Eintrag

Consider gastric lavage only if within one hour of a potentially fatal overdose. Give 50 grams of charcoal if within one hour of ingestion. Prolonged resuscitation may be successful in case of cardiac arrest. Give sodium bicarbonate in case of arrhythmias. (A311)

Health Effects · 1 Eintrag

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

Amitriptyline is rapidly and well absorbed following oral administration. Exclusively hepatic, with first pass effect. Amitriptyline is demethylated in the liver to its primary active metabolite, nortriptyline. Route of Elimination: Virtually the entire dose is excreted as glucuronide or sulfate conjugate of metabolites, with little unchanged drug appearing in the urine. 25-50% of a single orally administered dose is excreted in urine as inactive metabolites within 24 hours. Small amounts are excreted in feces via biliary elimination. Half Life: 10 to 50 hours, with an average of 15 hours

FDA Pharmacological Classification · 4 Einträge

AMITRIPTYLINE HCL

Tricyclic Antidepressant [EPC]

AMITRIPTYLINE HYDROCHLORIDE

Tricyclic Antidepressant [EPC]

MeSH Pharmacological Classification · 3 Einträge

Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.

A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.

Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.

Verwendung und Herstellung

UsesFor the treatment of depression, chronic pain, irritable bowel syndrome, sleep disorders, diabetic neuropathy, agitation and insomnia, and migraine prophylaxis.

Zugehörige Reaktionen

2
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 990584
HRID 990584als Edukt
Reaktionsgleichung von HRID 990585
HRID 990585als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
UNII
26LUD4JO9K
EC Number
208-964-6
14 · 14,487
Henry's Law Constant
1.4 · 1.4×102 mol/(m3Pa) at 25℃, HSDB (2015)
BCS Class
1 · 1
InChI
InChI=1S/C20H23N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-12H,7,13-15H2,1-2H3;1H
InChIKey
KFYRPLNVJVHZGT-UHFFFAOYSA-N
SMILES
CN(CC/C=C1/C2=C(C=CC=C2)CCC2=C/1C=CC=C2)C.[H]Cl
CAS Datenbank
549 · 549-18-8(CAS DataBase Reference)
EPA chemische Informationen
Amitriptyline hydrochloride (549-18-8)

Some rare side effects include tinnitus, hypotension, mania, psychosis, heart block, arrhythmias, lip and mouth ulcers, extrapyramidal symptoms, depression, and hepatic toxicity.Amitriptyline exhibits strong anticholinergic activity, cardiovascular effects including orthostatic hypotension, changes in heart rhythm and conduction, and a lowering of the seizure threshold (A308, L1032).

Exposure RoutesOral (A308) Rapidly and well absorbed following oral administration (bioavailability is 30-60% due to first pass metabolism). Peak plasma concentrations occur 2-12 hours following oral or intramuscular administration.
Toxicity Summary · 1 Eintrag

Amitriptyline is metabolized to nortriptyline which inhibits the reuptake of norepinephrine and serotonin almost equally. Amitriptyline inhibits the membrane pump mechanism responsible for uptake of norepinephrine and serotonin in adrenergic and serotonergic neurons. Pharmacologically this action may potentiate or prolong neuronal activity since reuptake of these biogenic amines is important physiologically in terminating transmitting activity. This interference with the reuptake of norepinephrine and/or serotonin is believed by some to underlie the antidepressant activity of amitriptyline.

Signs and Symptoms · 1 Eintrag

Symptoms of overdose include abnormally low blood pressure, confusion, convulsions, dilated pupils and other eye problems, disturbed concentration, drowsiness, hallucinations, impaired heart function, rapid or irregular heartbeat, reduced body temperature, stupor, and unresponsiveness or coma. Side effects include: sedation, hypotension, blurred vision, dry mouth, constipation, urinary retention, postural hypotension, tachycardia, hypertension, ECG changes, heart failure, impaired memory and delirium, and precipitation of hypomanic or manic episodes in bipolar depression. Withdrawal symptoms include gastrointestinal disturbances, anxiety, and insomnia.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Amitriptyline hydrochloride

vLess-DILI-concern

5

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Toxicity DataLD50: 350 mg/kg (Oral, Mouse) (A308)

Sicherheitsdaten

wgk
3
tsca
TSCA listed
ridadr
UN 2811 6.1/PG 3
hs_code
29214990
RTECS-Nr.
HO9450000
risk_code
23/24/25-36/37/38-42/43-63-39/23/24/25-11-50/53-36-22
Toxizität
LD50 in mice, rats (mg/kg): 350, 380 orally; 65, 75 i.p. (Tobe)
hazard_code
T,F,N,Xn
safety_code
22-26-36/37/39-45-36/37-16-61-60-7
hazard_class
6.1(b)
packing_group
III
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
Acute Tox. 3 OralAquatic Acute 1Aquatic Chronic 1Eye Irrit. 2Repr. 2
General Manufacturing Information1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride (1:1): INACTIVE
Anwendungen · 2 Einträge

BeschreibungAmitriptyline (hydrochloride) (CRM) (Item No. 19031) is a certified reference material categorized as a tricyclic antidepressant. This product is intended for analytical forensic applications. This product is also available as a general research tool .

VerwendenAmitriptyline hydrochloride is a tricyclic antidepressant drug. Amitriptyline hydrochloride inhibits the norepinephrine and serotonin transporters but has a high affinity for α1-adrenergic, serotonin and muscarinic acetylcholine receptors.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

4-Methylen-2-oxetanonAmitriptylinDiethyletherAmmoniumchloridDilute hydrochloric acidDiphosphorpentaoxidPhenylessigsureWasserstoffHydrogenchloridPhthalsureanhydrid3-Chlorpropyl(dimethyl)amin